Prostate cancer Research International: Active Surveillance (PRIAS) MRI study

Prostate cancer Research International: Active Surveillance (PRIAS) MRI study - PRIAS + MRI

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON50734

Enrollment

Registered

2013-10-23

Start date

2014-03-17

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate cancer prostate carcinoma

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1) Included into the PRIAS study

Exclusion criteria

Exclusion criteria: 1) Men who cannot or do not want to be irradiated or operated 2) A former therapy for prostate cancer 3) Men with a contraindication for MR

Design outcomes

Primary

Measure	Time frame
The main endpoint is the percentage of men upgraded (Gleason score >=7) at inclusion and at repeat biopsies.	—

Secondary

Measure	Time frame
Secondary endpoints are the therapy free survival rate, number of biopsies performed, biopsy complications, results after deferred radical treatment, development of metastasis and prostate cancer specific mortality.	—

Countries

Netherlands

Outcome results